Literature DB >> 29650091

Cardiovascular Protection in People With Diabetes.

James A Stone, Robyn L Houlden, Peter Lin, Jacob A Udell, Subodh Verma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29650091     DOI： 10.1016/j.jcjd.2017.10.024

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN： 1499-2671            Impact factor:   4.190


× No keyword cloud information.
  11 in total

1.  Trends in cardiovascular care and event rates among First Nations and other people with diabetes in Ontario, Canada, 1996-2015.

Authors:  Anna Chu; Lu Han; Idan Roifman; Douglas S Lee; Michael E Green; Kristen Jacklin; Jennifer Walker; Roseanne Sutherland; Shahriar Khan; Eliot Frymire; Jack V Tu; Baiju R Shah
Journal:  CMAJ       Date:  2019-11-25       Impact factor: 8.262

2.  Use of low-dose acetylsalicylic acid for cardiovascular disease prevention: A practical, stepwise approach for pharmacists.

Authors:  Arden R Barry; William M Semchuk; Ann Thompson; Marlys H LeBras; Sheri L Koshman
Journal:  Can Pharm J (Ott)       Date:  2020-03-19

3.  Diabetes and Platelet Response to Low-Dose Aspirin.

Authors:  Mohammed E Al-Sofiani; Lisa R Yanek; Nauder Faraday; Brian G Kral; Rasika Mathias; Lewis C Becker; Diane M Becker; Dhananjay Vaidya; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

4.  Impact of updated recommendations on acetylsalicylic acid use for primary prevention of cardiovascular disease in Canada: a population-based survey.

Authors:  Myriam Khalili; Fanny Lepeytre; Jason Robert Guertin; Rémi Goupil; Stéphan Troyanov; Josée Bouchard; François Madore
Journal:  CMAJ Open       Date:  2020-01-28

5.  Primary and Secondary Cardiovascular Prevention Among First Nations Peoples With Type 2 Diabetes in Canada: Findings From the FORGE AHEAD Program.

Authors:  Romina Pace; Stewart Harris; Monica Parry; Harsh Zaran
Journal:  CJC Open       Date:  2020-07-09

Review 6.  Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.

Authors:  Volker Vallon; Subodh Verma
Journal:  Annu Rev Physiol       Date:  2020-11-16       Impact factor: 19.318

7.  Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study.

Authors:  Michelle Greiver; Sumeet Kalia; Rahim Moineddin; Simon Chen; Raquel Duchen; Alanna Rigobon
Journal:  BMC Health Serv Res       Date:  2020-05-01       Impact factor: 2.655

Review 8.  Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.

Authors:  Chaicharn Deerochanawong; Siew P Chan; Bien J Matawaran; Wayne H-H Sheu; Juliana Chan; Nguyen H Man; Ketut Suastika; Chin M Khoo; Kun-Ho Yoon; Andrea Luk; Ambrish Mithal; Ji Linong
Journal:  Diabetes Obes Metab       Date:  2019-07-17       Impact factor: 6.577

9.  A Unique Multi- and Interdisciplinary Cardiology-Renal-Endocrine Clinic: A Description and Assessment of Outcomes.

Authors:  Lisa Dubrofsky; Jason F Lee; Parisa Hajimirzarahimshirazi; Hongyan Liu; Alanna Weisman; Patrick R Lawler; Michael E Farkouh; Jacob A Udell; David Z Cherney
Journal:  Can J Kidney Health Dis       Date:  2022-02-28

10.  Using concept mapping to prioritize barriers to diabetes care and self-management for those who experience homelessness.

Authors:  Eshleen K Grewal; Rachel B Campbell; Gillian L Booth; Kerry A McBrien; Stephen W Hwang; Patricia O'Campo; David J T Campbell
Journal:  Int J Equity Health       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.